Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials

Jesper Brok; Lise L Gluud; Christian Gluud

doi:10.1111/j.1572-0241.2006.00505.x

Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials

Jesper Brok, Lise L Gluud, Christian Gluud

Copenhagen Trial Unit

38 Citations (Scopus)

Abstract

Adding ribavirin to interferon improves treatment response for patients with chronic hepatitis C, but the effects of ribavirin monotherapy are unclear. We conducted a systematic review to assess the benefits and harms of ribavirin monotherapy for patients with chronic hepatitis C.

Original language	English
Journal	American Journal of Gastroenterology
Volume	101
Issue number	4
Pages (from-to)	842-7
Number of pages	6
ISSN	0002-9270
DOIs	https://doi.org/10.1111/j.1572-0241.2006.00505.x
Publication status	Published - Apr 2006

Keywords

Antiviral Agents
Hepatitis C, Chronic
Humans
Randomized Controlled Trials as Topic
Ribavirin

Access to Document

10.1111/j.1572-0241.2006.00505.x

Cite this

@article{1a592b69824c4596a6eee70a22e98974,

title = "Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials",

abstract = "Adding ribavirin to interferon improves treatment response for patients with chronic hepatitis C, but the effects of ribavirin monotherapy are unclear. We conducted a systematic review to assess the benefits and harms of ribavirin monotherapy for patients with chronic hepatitis C.",

keywords = "Antiviral Agents, Hepatitis C, Chronic, Humans, Randomized Controlled Trials as Topic, Ribavirin",

author = "Jesper Brok and Gluud, {Lise L} and Christian Gluud",

year = "2006",

month = apr,

doi = "10.1111/j.1572-0241.2006.00505.x",

language = "English",

volume = "101",

pages = "842--7",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Wolters Kluwer Health",

number = "4",

}

TY - JOUR

T1 - Ribavirin monotherapy for chronic hepatitis C infection

T2 - a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials

AU - Brok, Jesper

AU - Gluud, Lise L

AU - Gluud, Christian

PY - 2006/4

Y1 - 2006/4

N2 - Adding ribavirin to interferon improves treatment response for patients with chronic hepatitis C, but the effects of ribavirin monotherapy are unclear. We conducted a systematic review to assess the benefits and harms of ribavirin monotherapy for patients with chronic hepatitis C.

AB - Adding ribavirin to interferon improves treatment response for patients with chronic hepatitis C, but the effects of ribavirin monotherapy are unclear. We conducted a systematic review to assess the benefits and harms of ribavirin monotherapy for patients with chronic hepatitis C.

KW - Antiviral Agents

KW - Hepatitis C, Chronic

KW - Humans

KW - Randomized Controlled Trials as Topic

KW - Ribavirin

U2 - 10.1111/j.1572-0241.2006.00505.x

DO - 10.1111/j.1572-0241.2006.00505.x

M3 - Journal article

C2 - 16494584

SN - 0002-9270

VL - 101

SP - 842

EP - 847

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

IS - 4

ER -

Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials

Abstract

Keywords

Access to Document

Fingerprint

Cite this